CAS 5027-67-8: Benzeneacetic acid, α-[(acetyloxy)methyl]-, 9-methyl-3-oxa-9-azatricyclo[3.3.1.02,4]non-7-yl ester, hydrobromide, [7(S)-(1α,2β,4β,5α,7β)]-

Applications Scopolamine Hydrobromide (S200000) derivative. An acetylcholine antagonist. Used in treatment of motion sickness; antiemetic; antispasmodic; mydriatic; preanesthetic medicant. Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package References Brand, J.J., et al.: Lancet, 2, 232 (1970), Bowles, J.B., et al.: Anaesthesia, 34, 476 (1979), Clissold, S.P., et al.: Drugs, 29, 189 (1985), Muhtadi, F.J., et al.: Anal. Profiles Drug Subs., 19, 477 (1990),

Scopolamine is a muscarinic antagonist that is used to prevent motion sickness and the nausea and vomiting associated with anesthesia. It is an ester of scopolamine with hydrobromic acid. Scopolamine hydrobromide has been shown to have similar effects on humans as it does on rats. It is absorbed through the skin and metabolized in the liver, where it is excreted in bile and eliminated through the urinary system. The elimination half-life of scopolamine hydrobromide in humans ranges from 1 to 3 hours, which means that its effects wear off after about three hours.